These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22153983)

  • 1. Results of molecular docking as descriptors to predict human serum albumin binding affinity.
    Chen L; Chen X
    J Mol Graph Model; 2012 Mar; 33():35-43. PubMed ID: 22153983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of human serum albumin binding sites by docking and molecular dynamics flexible ligand-protein interactions.
    Deeb O; Rosales-Hernández MC; Gómez-Castro C; Garduño-Juárez R; Correa-Basurto J
    Biopolymers; 2010 Feb; 93(2):161-70. PubMed ID: 19785033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems.
    Gunturi SB; Narayanan R; Khandelwal A
    Bioorg Med Chem; 2006 Jun; 14(12):4118-29. PubMed ID: 16504519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative correlation between theoretical molecular descriptors and drug-HSA binding affinities for various cox-2 inhibitors.
    Seedher N; Bhatia S; Singh B
    Chem Biol Drug Des; 2008 Oct; 72(4):297-302. PubMed ID: 18844676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated in silico analysis of drug-binding to human serum albumin.
    Estrada E; Uriarte E; Molina E; Simón-Manso Y; Milne GW
    J Chem Inf Model; 2006; 46(6):2709-24. PubMed ID: 17125211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico prediction of human serum albumin binding for drug leads.
    Vallianatou T; Lambrinidis G; Tsantili-Kakoulidou A
    Expert Opin Drug Discov; 2013 May; 8(5):583-95. PubMed ID: 23461733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling drug albumin binding affinity with e-state topological structure representation.
    Hall LM; Hall LH; Kier LB
    J Chem Inf Comput Sci; 2003; 43(6):2120-8. PubMed ID: 14632464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR models for the prediction of binding affinities to human serum albumin using the heuristic method and a support vector machine.
    Xue CX; Zhang RS; Liu HX; Yao XJ; Liu MC; Hu ZD; Fan BT
    J Chem Inf Comput Sci; 2004; 44(5):1693-700. PubMed ID: 15446828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding modes of flavones to human serum albumin: insights from experimental and computational studies.
    Liu H; Bao W; Ding H; Jang J; Zou G
    J Phys Chem B; 2010 Oct; 114(40):12938-47. PubMed ID: 20845951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
    Simard JR; Zunszain PA; Hamilton JA; Curry S
    J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.
    Prado-Prado F; García-Mera X; Escobar M; Sobarzo-Sánchez E; Yañez M; Riera-Fernandez P; González-Díaz H
    Eur J Med Chem; 2011 Dec; 46(12):5838-51. PubMed ID: 22005185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting human plasma protein binding of drugs using plasma protein interaction QSAR analysis (PPI-QSAR).
    Li H; Chen Z; Xu X; Sui X; Guo T; Liu W; Zhang J
    Biopharm Drug Dispos; 2011 Sep; 32(6):333-42. PubMed ID: 21800312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of blood-brain partitioning and human serum albumin binding based on COSMO-RS sigma-moments.
    Wichmann K; Diedenhofen M; Klamt A
    J Chem Inf Model; 2007; 47(1):228-33. PubMed ID: 17238268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fast liquid chromatographic method to determine compounds binding to human serum albumin].
    Valkó K
    Acta Pharm Hung; 2003; 73(1):13-22. PubMed ID: 12891895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics simulation and binding studies of beta-sitosterol with human serum albumin and its biological relevance.
    Sudhamalla B; Gokara M; Ahalawat N; Amooru DG; Subramanyam R
    J Phys Chem B; 2010 Jul; 114(27):9054-62. PubMed ID: 20565066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions.
    Kawakami A; Kubota K; Yamada N; Tagami U; Takehana K; Sonaka I; Suzuki E; Hirayama K
    FEBS J; 2006 Jul; 273(14):3346-57. PubMed ID: 16857017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists.
    Dastmalchi S; Hamzeh-Mivehroud M; Ghafourian T; Hamzeiy H
    J Mol Graph Model; 2008 Jan; 26(5):834-44. PubMed ID: 17561422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico prediction of drug-binding strengths to human serum albumin.
    Colmenarejo G
    Med Res Rev; 2003 May; 23(3):275-301. PubMed ID: 12647311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of anthracycline disaccharide with human serum albumin: investigation by fluorescence spectroscopic technique and modeling studies.
    Cui F; Qin L; Zhang G; Liu Q; Yao X; Lei B
    J Pharm Biomed Anal; 2008 Nov; 48(3):1029-36. PubMed ID: 18722067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.
    Lambrinidis G; Vallianatou T; Tsantili-Kakoulidou A
    Adv Drug Deliv Rev; 2015 Jun; 86():27-45. PubMed ID: 25819487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.